Cargando…

t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension

AIM: The aim of the present study was to identify the possible genotypic association of 3’UTR Hind III polymorphism of Plasminogen activator Inhibitor-1 (PAI-1) gene with idiopathic pulmonary arterial hypertension (IPAH). BACKGROUND: IPAH is a disorder with abnormally raised mean pulmonary arterial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katta, Sujana, Vadapalli, Shivani, Sastry, B. K. S., Nallari, Pratibha
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840792/ https://www.ncbi.nlm.nih.gov/pubmed/20300292 http://dx.doi.org/10.4103/0971-6866.44103

Ejemplares similares

Epistatic interactions in idiopathic pulmonary arterial hypertension
por: Vadapalli, Shivani, et al.
Publicado: (2012)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
por: Kim, Hong-Soo, et al.
Publicado: (2003)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
por: Raman, Srishty, et al.
Publicado: (2021)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Upregulated Genes In Sporadic, Idiopathic Pulmonary Arterial Hypertension
por: Edgar, Alasdair J, et al.
Publicado: (2006)

Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension
por: Yan, Lu, et al.
Publicado: (2020)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension
por: Wang, Ziran, et al.
Publicado: (2023)

Arterial methemoglobin level predicts therapeutic effectiveness of the PDE5 inhibitors in patients with in idiopathic pulmonary arterial hypertension
por: Tamura, Yuichi, et al.
Publicado: (2011)

Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
por: van der Have, Oscar, et al.
Publicado: (2023)

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population
por: Park, Han Sung, et al.
Publicado: (2020)

Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension
por: Tio, Darryl, et al.
Publicado: (2013)

The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification
por: Shaireen, Huma, et al.
Publicado: (2013)

Hoarseness of voice as presenting complaint of idiopathic pulmonary arterial hypertension
por: Garg, Rajiv, et al.
Publicado: (2017)

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension
por: Jones, Rowena J., et al.
Publicado: (2022)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
por: Hoeper, Marius M, et al.
Publicado: (2022)

Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey
por: Dutilleux, Tanguy, et al.
Publicado: (2023)

Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
por: Regalado, Luis, et al.
Publicado: (2021)

A giant pulmonary artery aneurysm in a patient with severe idiopathic pulmonary arterial hypertension
por: Sonaglioni, Andrea, et al.
Publicado: (2022)

Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients
por: Radchenko, GD, et al.
Publicado: (2020)

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry
por: DuBrock, Hilary M., et al.
Publicado: (2021)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Evaluation of Interleukin-10 (G-1082A) Promoter Polymorphism in Preeclampsia
por: Sowmya, Sabnavis, et al.
Publicado: (2013)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Transferrin (rs3811647) gene polymorphism in iron deficiency anemia
por: Manjari, K Sri, et al.
Publicado: (2014)

Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady
por: Kurtul, Bengi Ece, et al.
Publicado: (2020)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Heart-lung transplantation for idiopathic pulmonary arterial hypertension and giant pulmonary artery aneurysm – case report
por: Eadington, T., et al.
Publicado: (2020)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_atb8ab2u3585ho6s73rco8i1v8